share_log

SQI Diagnostics Inc. (OTCMKTS:SQIDF) Sees Large Growth in Short Interest

SQI Diagnostics Inc. (OTCMKTS:SQIDF) Sees Large Growth in Short Interest

SQI診斷公司(場外市場代碼:SQIDF)看到空頭股數的巨大增長
Defense World ·  2022/11/15 14:53

SQI Diagnostics Inc. (OTCMKTS:SQIDF – Get Rating) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 36,800 shares, an increase of 18.7% from the October 15th total of 31,000 shares. Based on an average daily volume of 159,500 shares, the short-interest ratio is presently 0.2 days.

SQI Diagnostics Inc.(場外市場代碼:SQIDF-GET Rating)在10月份見證了空頭股數的大幅增長。截至10月31日,空頭股數共有3.68萬股,比10月15日的3.1萬股增加了18.7%。以日均成交量159,500股計算,目前短息比為0.2天。

SQI Diagnostics Stock Performance

SQI診斷公司股票表現

Shares of OTCMKTS:SQIDF opened at $0.09 on Tuesday. SQI Diagnostics has a 1 year low of $0.06 and a 1 year high of $0.18. The stock's 50-day moving average is $0.08 and its 200 day moving average is $0.11.

週二,OTCMKTS:SQIDF的股價開盤報0.09美元。SQI診斷公司的一年低點為0.06美元,一年高位為0.18美元。該股的50日移動均線切入位在0.08美元,200日移動均線切入位在0.11美元。

Get
到達
SQI Diagnostics
SQI診斷
alerts:
警報:

About SQI Diagnostics

關於SQI診斷公司

(Get Rating)

(獲取評級)

SQI Diagnostics Inc, a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. It also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test.
SQI診斷公司是一家精密醫療公司,為世界各地的醫療保健提供者、患者和消費者發現、開發和商業化快速診斷測試服務。它還提供TOR-DX肺部測試,使外科醫生能夠評估捐贈者的肺健康狀況;新冠肺炎在家抗體檢測試劑盒;RALI-Dx,新冠肺炎嚴重性分類實驗室測試;以及RALI-FAST,新冠肺炎嚴重性分類POC測試。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on SQI Diagnostics (SQIDF)
  • Take Two Interactive Software Stock is Taking One Step Back
  • This Mid-Cap Tech Stock Embodies Diversified Growth
  • Why did NIO take a $581.11 million loss last quarter?
  • Is It Time To Take A Ride With Joby Aviation's EV Innovations?
  • After a $100 Haircut, is Catalent an Oversold Pharma Play?
  • 免費獲取StockNews.com關於SQI診斷的研究報告(SQIDF)
  • 交互軟件股票後退一步
  • 這隻中型科技股體現了多元化的增長
  • 為什麼上個季度蔚來虧損5.811億美元?
  • 是時候與Joby Aviation的電動汽車創新一起兜風了嗎?
  • 在100美元的理髮之後,Catalent是一個超賣的製藥公司嗎?

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.

接收SQI診斷日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對SQI診斷和相關公司的最新新聞和分析師評級的每日簡明摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論